Identification and Validation of Differentially Expressed Proteins in Epithelial Ovarian Cancers Using Quantitative Proteomics

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Nov 9

PMID 27825122

Citations 24

Authors

Hong Qu

Yuling Chen

Guangming Cao

Chongdong Liu

Jiatong Xu

Haiteng Deng

Zhenyu Zhang

Affiliations

Soon will be listed here.

Abstract

Ovarian cancer is the most lethal gynecological malignant tumor because of its high recurrence rate. In the present work, in order to find new therapeutic targets, we identified 8480 proteins in thirteen pairs of ovarian cancer tissues and normal ovary tissues through quantitative proteomics. 498 proteins were found to be differentially expressed in ovarian cancer, which involved in various cellular processes, including metabolism, response to stimulus and biosynthetic process. The expression levels of chloride intracellular channel protein 1 (CLIC1) and lectin galactoside-binding soluble 3 binding protein (LGALS3BP) in epithelial ovarian cancer tissues were significantly higher than those in normal ovary tissues as confirmed by western blotting and immunohistochemistry. The knockdown of CLIC1 in A2780 cell line downregulated expression of CTPS1, leading to the decrease of CTP and an arrest of cell cycle G1 phase, which results into a slower proliferation. CLIC1-knockdown can also slow down the tumor growth in vivo. Besides, CLIC1-knockdown cells showed an increased sensitivity to hydrogen peroxide and cisplatin, suggesting that CLIC1 was involved in regulation of redox and drug resistance in ovarian cancer cells. These results indicate CLIC1 promotes tumorgenesis, and is a potential therapeutic target in epithelial ovarian cancer treatment.

Citing Articles

Proteomic landscape of epithelial ovarian cancer.

Qian L, Zhu J, Xue Z, Zhou Y, Xiang N, Xu H Nat Commun. 2024; 15(1):6462.

PMID: 39085232 PMC: 11291745. DOI: 10.1038/s41467-024-50786-z.

Cytidine triphosphate synthase 1-mediated metabolic reprogramming promotes proliferation and drug resistance in multiple myeloma.

Huang H, Chen Y, Li Y, Zheng X, Shu L, Tian L Heliyon. 2024; 10(13):e33001.

PMID: 39050461 PMC: 11268195. DOI: 10.1016/j.heliyon.2024.e33001.

CA9, CYFIP2 and LGALS3BP-A Novel Biomarker Panel to Aid Prognostication in Glioma.

Hudson A, Cho A, Colvin E, Hayes S, Wheeler H, Howell V Cancers (Basel). 2024; 16(5).

PMID: 38473425 PMC: 10931055. DOI: 10.3390/cancers16051069.

Ion Channels and Personalized Medicine in Gynecological Cancers.

Ramirez A, Ogonaga-Borja I, Acosta B, Chiliquinga A, de la Garza J, Gariglio P Pharmaceuticals (Basel). 2023; 16(6).

PMID: 37375748 PMC: 10303675. DOI: 10.3390/ph16060800.

Resistance prediction in high-grade serous ovarian carcinoma with neoadjuvant chemotherapy using data-independent acquisition proteomics and an ovary-specific spectral library.

Qian L, Zhu J, Xue Z, Gong T, Xiang N, Yue L Mol Oncol. 2023; 17(8):1567-1580.

PMID: 36855266 PMC: 10399723. DOI: 10.1002/1878-0261.13410.

References

Wang L, Tong S, Hu H, Ye F, Li S, Ren H . Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach. J Cell Biochem. 2012; 113(12):3762-72. DOI: 10.1002/jcb.24250. View

Shewach D . Quantitation of deoxyribonucleoside 5'-triphosphates by a sequential boronate and anion-exchange high-pressure liquid chromatographic procedure. Anal Biochem. 1992; 206(1):178-82. DOI: 10.1016/s0003-2697(05)80030-2. View

Stampolidis P, Ullrich A, Iacobelli S . LGALS3BP, lectin galactoside-binding soluble 3 binding protein, promotes oncogenic cellular events impeded by antibody intervention. Oncogene. 2013; 34(1):39-52. DOI: 10.1038/onc.2013.548. View

Martin E, Palmic N, Sanquer S, Lenoir C, Hauck F, Mongellaz C . CTP synthase 1 deficiency in humans reveals its central role in lymphocyte proliferation. Nature. 2014; 510(7504):288-92. PMC: 6485470. DOI: 10.1038/nature13386. View

Setti M, Osti D, Richichi C, Ortensi B, Del Bene M, Fornasari L . Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth. Oncotarget. 2015; 6(31):31413-27. PMC: 4741615. DOI: 10.18632/oncotarget.5105. View

Petricoin E, Ardekani A, Hitt B, Levine P, Fusaro V, Steinberg S . Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002; 359(9306):572-7. DOI: 10.1016/S0140-6736(02)07746-2. View

Harrop S, DeMaere M, Fairlie W, Reztsova T, Valenzuela S, Mazzanti M . Crystal structure of a soluble form of the intracellular chloride ion channel CLIC1 (NCC27) at 1.4-A resolution. J Biol Chem. 2001; 276(48):44993-5000. DOI: 10.1074/jbc.M107804200. View

de Korte D, Haverkort W, Roos D, Behrendt H, van Gennip A . Imbalance in the ribonucleotide pools of lymphoid cells from acute lymphoblastic leukemia patients. Leuk Res. 1986; 10(4):389-96. DOI: 10.1016/0145-2126(86)90068-8. View

Fogeron M, Muller H, Schade S, Dreher F, Lehmann V, Kuhnel A . LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. Nat Commun. 2013; 4:1531. DOI: 10.1038/ncomms2517. View

10.

Williams J, Kizaki H, Weber G, MORRIS H . Increased CTP synthetase activity in cancer cells. Nature. 1978; 271(5640):71-3. DOI: 10.1038/271071a0. View

11.

de Korte D, Haverkort W, van Gennip A, Roos D . Nucleotide profiles of normal human blood cells determined by high-performance liquid chromatography. Anal Biochem. 1985; 147(1):197-209. DOI: 10.1016/0003-2697(85)90028-4. View

12.

Zhang S, Wang X, Yin Z, Zhao W, Zhou J, Zhao B . Chloride intracellular channel 1 is overexpression in hepatic tumor and correlates with a poor prognosis. APMIS. 2013; 121(11):1047-53. DOI: 10.1111/apm.12093. View

13.

de Korte D, Haverkort W, Roos D, van Gennip A . Aberrant ribonucleotide pattern in lymphoid cells from patients with chronic lymphocytic leukaemia or non-Hodgkin lymphoma. Int J Cancer. 1987; 40(2):192-7. DOI: 10.1002/ijc.2910400211. View

14.

Long C, Levitzki A, Koshland Jr D . The subunit structure and subunit interactions of cytidine triphosphate synthetase. J Biol Chem. 1970; 245(1):80-7. View

15.

Zhang B, Cai F, Zhong X . An overview of biomarkers for the ovarian cancer diagnosis. Eur J Obstet Gynecol Reprod Biol. 2011; 158(2):119-23. DOI: 10.1016/j.ejogrb.2011.04.023. View

16.

Valenzuela S, Martin D, Por S, Robbins J, Warton K, Bootcov M . Molecular cloning and expression of a chloride ion channel of cell nuclei. J Biol Chem. 1997; 272(19):12575-82. DOI: 10.1074/jbc.272.19.12575. View

17.

Harmenberg J, Cox S . Improved sample preparation method for high-performance liquid chromatography of deoxyribonucleoside triphosphates from cell culture extracts. J Chromatogr. 1990; 508(1):75-9. DOI: 10.1016/s0021-9673(00)91241-x. View

18.

Sidi Y, Edwards N, Winkler C, Bunn P, Mitchell B . Differential metabolism of deoxyribonucleosides by leukaemic T cells of immature and mature phenotype. Br J Haematol. 1985; 61(1):125-34. DOI: 10.1111/j.1365-2141.1985.tb04067.x. View

19.

Wang L, He S, Tu Y, Ji P, Zong J, Zhang J . Elevated expression of chloride intracellular channel 1 is correlated with poor prognosis in human gliomas. J Exp Clin Cancer Res. 2012; 31:44. PMC: 3441274. DOI: 10.1186/1756-9966-31-44. View

20.

de Korte D, Haverkort W, de Boer M, van Gennip A, Roos D . Imbalance in the nucleotide pools of myeloid leukemia cells and HL-60 cells: correlation with cell-cycle phase, proliferation, differentiation, and transformation. Cancer Res. 1987; 47(7):1841-7. View